Synthesis and biological evaluation of new amino acids structurally related to the antitumor agent acivicin. 2003

Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
Istituto di Chimica Farmaceutica, Università di Milano, viale Abruzzi 42, Milano 20131, Italy. paola.conti@unimi.it

A set of racemic conformationally constrained analogues of the antitumor antibiotic acivicin (+)-1 has been prepared through a strategy based on 1,3-dipolar cycloaddition of bromonitrile oxide to suitable dipolarophiles. The bromo analogue (2) of acivicin was also synthesized and tested as a reference compound, together with its stereoisomer 3. The antitumor properties of novel amino acids 4-7 were evaluated in vitro against human tumor cell lines. Their efficacy to inhibit glutamate synthase (GltS) from Azospirillum brasilense was also assayed. None of the studied compounds, but 2, showed significant activity.

UI MeSH Term Description Entries
D007555 Isoxazoles Azoles with an OXYGEN and a NITROGEN next to each other at the 1,2 positions, in contrast to OXAZOLES that have nitrogens at the 1,3 positions. Isoxazole
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D004791 Enzyme Inhibitors Compounds or agents that combine with an enzyme in such a manner as to prevent the normal substrate-enzyme combination and the catalytic reaction. Enzyme Inhibitor,Inhibitor, Enzyme,Inhibitors, Enzyme
D005970 Glutamate Synthase An enzyme that catalyzes the formation of 2 molecules of glutamate from glutamine plus alpha-ketoglutarate in the presence of NADPH. EC 1.4.1.13. Glutamine Ketoglutarate Amidotransferase,Ketoglutarate Glutamine Amidotransferase,Amidotransferase, Glutamine Ketoglutarate,Amidotransferase, Ketoglutarate Glutamine,Glutamine Amidotransferase, Ketoglutarate,Ketoglutarate Amidotransferase, Glutamine,Synthase, Glutamate
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000596 Amino Acids Organic compounds that generally contain an amino (-NH2) and a carboxyl (-COOH) group. Twenty alpha-amino acids are the subunits which are polymerized to form proteins. Amino Acid,Acid, Amino,Acids, Amino
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013237 Stereoisomerism The phenomenon whereby compounds whose molecules have the same number and kind of atoms and the same atomic arrangement, but differ in their spatial relationships. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 5th ed) Molecular Stereochemistry,Stereoisomers,Stereochemistry, Molecular,Stereoisomer
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
March 1981, The Journal of pharmacology and experimental therapeutics,
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
September 1992, Journal of medicinal chemistry,
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
February 1989, Research communications in chemical pathology and pharmacology,
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
January 1994, Drug metabolism and drug interactions,
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
April 2012, Molecules (Basel, Switzerland),
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
December 1977, Pharmacological reviews,
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
May 1985, Journal of medicinal chemistry,
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
January 2011, Bioorganic & medicinal chemistry letters,
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
December 1998, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Paola Conti, and Gabriella Roda, and Helena Stabile, and Maria Antonietta Vanoni, and Bruno Curti, and Marco De Amici
July 2002, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!